TX-MARY-KAY
Mary Kay Inc. , celebrating its 55th anniversary as a top beauty brand and direct seller in nearly 40 markets, announces the appointments of Chaun Harper as Senior Vice President – Chief Manufacturing Officer and Dr. Lucy Gildea as Senior Vice President – Chief Scientific Officer. In their new roles, Harper and Gildea will join the global cosmetics company’s executive team.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190124005055/en/
As Senior Vice President – Chief Manufacturing Officer, Chaun Harper will assume responsibility for global manufacturing operations, global inventory control, supply planning, transportation and global quality. Harper joined Mary Kay Inc. in 2014 as Director of Production Operations. During his tenure, Harper has been instrumental in creating a culture of continuous improvement at Mary Kay’s manufacturing facility including dramatically increasing production efficiency and implementing key development opportunities for employees to elevate technical skills and advance their careers. Prior to joining the iconic beauty company, Harper worked for L’Oréal where he held several positions within both the operations and quality functions.
As Senior Vice President – Chief Scientific Officer, Dr. Lucy Gildea will continue to lead Mary Kay Inc.’s research and development operations. Since joining the iconic beauty company in 2017 , Dr. Gildea has worked to execute the company’s global product strategy and innovation pipeline. With a global portfolio of more than 1,400 patents for products, technologies and packaging systems, Mary Kay has fostered a culture of innovation and invests millions of dollars annually in research and development. Dr. Gildea will be key in leading the company innovatively into the next generation. Prior to joining Mary Kay Inc., Dr. Gildea spent 15 years at Procter and Gamble, working in health care, oral care, beauty technology and beauty/skin development.
“In a relatively short period of time, both Chaun and Lucy have made significant contributions and proven to be instrumental in Mary Kay’s research, development, and supply chain operations,” said Deborah Gibbins, Chief Operating Officer for Mary Kay Inc. “In their new roles as members of the company’s executive team, Chaun and Lucy will work to ensure global and regional alignment of strategy and plans for Mary Kay® products. As one of the top innovators in the direct selling and cosmetic industries, Mary Kay is a cosmetics powerhouse with more than 700 products in our global portfolio. As we continue to produce best-in-the-industry products, we are proud to appoint Chaun and Lucy to these executive positions knowing their leadership and expertise will be invaluable as we build on our efforts to enrich women’s lives worldwide.”
Harper earned a Bachelor of Science in Chemistry from Arkansas Tech University in Russellville, Ark. and a Master of Business Administration from Webster University in St. Louis, Mo. Dr. Gildea earned a Bachelor of Science in Biology from Georgetown College in Georgetown, Ky. and a PhD in Cell and Molecular Biology, Immunology and Infectious Diseases from the University of Cincinnati.
About Mary Kay
At Mary Kay, success lies in our dedication to irresistible products, a rewarding opportunity and positive community impact. For 55 years, Mary Kay has inspired women to achieve their entrepreneurial goals in nearly 40 countries. As a multibillion-dollar company, we offer the latest in cutting-edge skin care, bold color cosmetics and fragrances. Discover more reasons to love Mary Kay at www.marykay.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190124005055/en/
Contact:
Mary Kay Inc. Corporate Communications marykay.com/newsroom 972.687.5332 or media@mkcorp.com
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
INFOBIP25.4.2024 09:01:30 CEST | Press release
Infobip becomes an Oracle Independent Software Vendor partner
LENOVO25.4.2024 05:01:26 CEST | Press release
Global CIOs geared up to scale AI but organizations aren’t as ready
MUNDIPHARMA24.4.2024 22:02:28 CEST | Press release
Mundipharma acquires all assets and rights related to REZZAYO® (rezafungin), reinforcing continued commitment to management of infectious diseases and specialty care therapeutic area
MA-BEIGENE24.4.2024 22:02:28 CEST | Press release
Global Oncology Innovator BeiGene Highlights New Data across Hematology and Solid Tumor Portfolio at 2024 ASCO Annual Meeting
CA-TSMC24.4.2024 21:31:27 CEST | Press release
TSMC Celebrates 30th North America Technology Symposium with Innovations Powering AI with Silicon Leadership
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom